-
Ethyl eicosapentaenoic acid (E-EPA,
icosapent ethyl), sold
under the
brand name
Vascepa among others, is a
medication used to
treat dyslipidemia and...
- triglycerides. In the REDUCE-IT trial,
patients on
statin therapy and 4g
daily of
icosapent ethyl saw a
reduction in
major cardiovascular events.
Lomitapide works...
- deciliter. In
December 2019, the FDA
approved "...the use of
Vascepa (
icosapent ethyl) as an
adjunctive (secondary)
therapy to
reduce the risk of cardiovascular...
-
Ballantyne CM (January 3, 2019). "Cardiovascular Risk
Reduction with
Icosapent Ethyl for Hypertriglyceridemia". New
England Journal of Medicine. 380...
- 2020. "Vascepa-
icosapent ethyl capsule". DailyMed. 30
January 2020.
Retrieved 12 May 2020. "Drug
Approval Package:
Vascepa (
icosapent ethyl) NDA #202057"...
- for the REDUCE-IT Investigators.
Cardiovascular risk
reduction with
icosapent ethyl for hypertriglyceridemia.NEJM. 2019;380:11-22. PMID 30415628 Cited...
- a
chemical solvent,
usually in the form of DIPE (diisopropyl ether)
Icosapent ethyl, that is,
ethyl eicosapentaenoic acid, an omega-3
lipid formulation...
- doi:10.3810/pgm.2014.11.2828. PMID 25387209. S2CID 12524547. "Vascepa (
icosapent ethyl)". CenterWatch.
Retrieved 31
March 2016. "Epanova (omega-3-carboxylic...
-
icoduline (INN)
icometasone enbutate (INN)
icomucret (USAN)
icopezil (INN)
icosapent (INN)
icospiramide (INN)
icrocaptide (INN)
Idamycin (Adria Laboratories)...
- versions).
Ethyl eicosapentaenoic acid (Vascepa, and 1
generic as
ethyl icosapent)
There are many fish oil
dietary supplements on the market.
There appears...
